Recent reports from Malaysia reveal a 45% increase in human metapneumovirus (HMPV) cases in 2024 compared to 2023. The ...

China’s National Disease Control and Prevention Administration recently reported an increase in respiratory infections, including HMPV, during the winter. The World Health Organisation (WHO) has not ...

Nearly five years after the Covid-19 pandemic, which claimed nearly seven million lives globally, unverified videos of ...

China is experiencing a surge in infections of a respiratory virus, leading to public concerns about an outbreak. The virus, ...

The respiratory syncytial virus (RSV) vaccine may not protect older adults who are immunocompromised as much as their healthier peers, according to new research.

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity -; primarily organ transplant recipients who take immunosuppressive medications to reduce the risk of ...

The study followed 38 immunocompromised adults, aged 64 to 72, who received either the Arexvy or Abrysvo RSV vaccine. Researchers found that people aged 60 and older who are immunocompromised ...

Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...

It’s the holiday season, and while people are looking forward to stuffing their faces with food or seeing loved ones after a ...

A brand of eye drops sold nationally has been recalled due to the presence of fungus, which may cause vision damage.